{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:02:55Z","timestamp":1793797375188,"version":"4.6.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Biruni University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01798-9","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:09:43Z","timestamp":1772266183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between gut microbiota and neurodegenerative diseases: a genetic and epigenetic perspective"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7908-2428","authenticated-orcid":false,"given":"Zeynep Bet\u00fcl","family":"Altan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0458-5638","authenticated-orcid":false,"given":"Murat","family":"Ihlamur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"11","key":"1798_CR1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300864RR","volume":"37","author":"J Ahmad","year":"2023","unstructured":"Ahmad J, Khan I, Zengin G, Mahomoodally MF (2023) The gut microbiome in the fight against obesity: the potential of dietary factors. FASEB J 37(11):e23258. https:\/\/doi.org\/10.1096\/fj.202300864RR","journal-title":"FASEB J"},{"key":"1798_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44:691\u2013707. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.064","journal-title":"EBioMedicine"},{"key":"1798_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Salami M (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8:256. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","journal-title":"Front Aging Neurosci"},{"key":"1798_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1407620","volume":"15","author":"H Alatan","year":"2024","unstructured":"Alatan H, Liang S, Shimodaira Y, Wu X, Hu X, Wang T, Jin F (2024) Supplementation with Lactobacillus helveticus NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression. Front Immunol 15:1407620. https:\/\/doi.org\/10.3389\/fimmu.2024.1407620","journal-title":"Front Immunol"},{"key":"1798_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223955","author":"N Al-Habsi","year":"2024","unstructured":"Al-Habsi N, Al-Khalili M, Haque SA, Elias M, Olqi NA, Al Uraimi T (2024) Health benefits of prebiotics, probiotics, synbiotics, and postbiotics. Nutrients. https:\/\/doi.org\/10.3390\/nu16223955","journal-title":"Nutrients"},{"issue":"7","key":"1798_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1139\/apnm-2017-0648","volume":"43","author":"S Athari Nik Azm","year":"2018","unstructured":"Athari Nik Azm S, Djazayeri A, Safa M, Azami K, Ahmadvand B, Sabbaghziarani F, Vafa M (2018) Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in \u03b2-amyloid (1-42) injected rats. Appl Physiol Nutr Metab 43(7):718\u2013726. https:\/\/doi.org\/10.1139\/apnm-2017-0648","journal-title":"Appl Physiol Nutr Metab"},{"key":"1798_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0278-4","volume":"15","author":"OA Baothman","year":"2016","unstructured":"Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M (2016) The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis 15:108. https:\/\/doi.org\/10.1186\/s12944-016-0278-4","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1798_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"key":"1798_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00044","volume":"9","author":"S Breit","year":"2018","unstructured":"Breit S, Kupferberg A, Rogler G, Hasler G (2018) Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders. Front Psychiatry 9:44. https:\/\/doi.org\/10.3389\/fpsyt.2018.00044","journal-title":"Front Psychiatry"},{"issue":"2","key":"1798_CR10","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28(2):203\u2013209","journal-title":"Ann Gastroenterol"},{"issue":"19","key":"1798_CR11","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1007\/s00253-020-10849-9","volume":"104","author":"C Celiker","year":"2020","unstructured":"Celiker C, Kalkan R (2020) Genetic and epigenetic perspective of microbiota. Appl Microbiol Biotechnol 104(19):8221\u20138229. https:\/\/doi.org\/10.1007\/s00253-020-10849-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1798_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00595-7","volume":"18","author":"S Chandra","year":"2023","unstructured":"Chandra S, Sisodia SS, Vassar RJ (2023) The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored. Mol Neurodegener 18(1):9. https:\/\/doi.org\/10.1186\/s13024-023-00595-7","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1798_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00307-1","volume":"6","author":"C Chen","year":"2025","unstructured":"Chen C, Wang GQ, Li DD, Zhang F (2025) Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Biomed 6(1):64. https:\/\/doi.org\/10.1186\/s43556-025-00307-1","journal-title":"Mol Biomed"},{"issue":"34","key":"1798_CR15","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1073\/pnas.0904489106","volume":"106","author":"TA Clayton","year":"2009","unstructured":"Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK (2009) Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A 106(34):14728\u201314733. https:\/\/doi.org\/10.1073\/pnas.0904489106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1798_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","volume":"148","author":"JC Clemente","year":"2012","unstructured":"Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148(6):1258\u20131270. https:\/\/doi.org\/10.1016\/j.cell.2012.01.035","journal-title":"Cell"},{"issue":"4","key":"1798_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1798_CR18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Dinan TG (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"issue":"1","key":"1798_CR19","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/advances\/nmy078","volume":"10","author":"A Cuevas-Sierra","year":"2019","unstructured":"Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA (2019) Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr 10(1):S17-s30. https:\/\/doi.org\/10.1093\/advances\/nmy078","journal-title":"Adv Nutr"},{"issue":"1","key":"1798_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01491-z","volume":"20","author":"AL Cunningham","year":"2021","unstructured":"Cunningham AL, Stephens JW, Harris DA (2021) A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 20(1):65. https:\/\/doi.org\/10.1186\/s12944-021-01491-z","journal-title":"Lipids Health Dis"},{"issue":"10","key":"1798_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72427","volume":"16","author":"BJ Dandamudi","year":"2024","unstructured":"Dandamudi BJ, Dimaano KAM, Shah N, AlQassab O, Al-Sulaitti Z, Nelakuditi B, Mohammed L (2024) Neurodegenerative disorders and the gut-microbiome-brain axis: a literature review. Cureus 16(10):e72427. https:\/\/doi.org\/10.7759\/cureus.72427","journal-title":"Cureus"},{"key":"1798_CR22","doi-asserted-by":"publisher","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Ghasemi Y (2019) Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. https:\/\/doi.org\/10.3390\/foods8030092","DOI":"10.3390\/foods8030092"},{"key":"1798_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.885031","author":"E Duarte-Silva","year":"2022","unstructured":"Duarte-Silva E, Meuth SG, Peixoto CA (2022) Microbial metabolites in multiple sclerosis: implications for pathogenesis and treatment. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2022.885031","journal-title":"Front Neurosci"},{"issue":"6","key":"1798_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/febs.17102","volume":"292","author":"MN Ekwudo","year":"2025","unstructured":"Ekwudo MN, Gubert C, Hannan AJ (2025) The microbiota\u2013gut\u2013brain axis in Huntington\u2019s disease: pathogenic mechanisms and therapeutic targets. FEBS J 292(6):1282\u20131315. https:\/\/doi.org\/10.1111\/febs.17102","journal-title":"FEBS J"},{"issue":"8","key":"1798_CR25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/glia.23822","volume":"68","author":"D Erny","year":"2020","unstructured":"Erny D, Prinz M (2020) How microbiota shape microglial phenotypes and epigenetics. Glia 68(8):1655\u20131672. https:\/\/doi.org\/10.1002\/glia.23822","journal-title":"Glia"},{"key":"1798_CR26","doi-asserted-by":"publisher","unstructured":"Fan J, Liu Q, Liu X, Gong M, Leong II, Tsang Y, . . . Zhuang L (2024) The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study. Front Endocrinol 15. Retrieved from https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/https:\/\/doi.org\/10.3389\/fendo.2024.1372518","DOI":"10.3389\/fendo.2024.1372518"},{"key":"1798_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105990","volume":"169","author":"N Faraji","year":"2025","unstructured":"Faraji N, Payami B, Ebadpour N, Gorji A (2025) Vagus nerve stimulation and gut microbiota interactions: a novel therapeutic avenue for neuropsychiatric disorders. Neurosci Biobehav Rev 169:105990. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105990","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"1798_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","volume":"9","author":"HJ Flint","year":"2012","unstructured":"Flint HJ, Scott KP, Louis P, Duncan SH (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9(10):577\u2013589. https:\/\/doi.org\/10.1038\/nrgastro.2012.156","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1798_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1432659","volume":"18","author":"Y Fu","year":"2024","unstructured":"Fu Y, Gu Z, Cao H, Zuo C, Huang Y, Song Y, Jiang Y, Wang F (2024) The role of the gut microbiota in neurodegenerative diseases targeting metabolism. Front Neurosci 18:1432659. https:\/\/doi.org\/10.3389\/fnins.2024.1432659","journal-title":"Front Neurosci"},{"key":"1798_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100056","volume":"3","author":"EM Gatto","year":"2020","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C (2020) Huntington disease: advances in the understanding of its mechanisms. Clin Park Relat Disord 3:100056. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100056","journal-title":"Clin Park Relat Disord"},{"issue":"8","key":"1798_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"1798_CR32","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa EZ (2020) Human gut microbiota\/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 113(12):2019\u20132040. https:\/\/doi.org\/10.1007\/s10482-020-01474-7","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"5","key":"1798_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.chom.2016.04.017","volume":"19","author":"JK Goodrich","year":"2016","unstructured":"Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, Goodrich J, Davenport E, Jackson M, Spector T, Bell J, Clark A, Ley R, Ley RE (2016a) Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19(5):731\u2013743. https:\/\/doi.org\/10.1016\/j.chom.2016.04.017","journal-title":"Cell Host Microbe"},{"key":"1798_CR34","doi-asserted-by":"publisher","unstructured":"Goodrich JK, Davenport, ER, Beaumont M, Jackson MA, Knight R, Ober C, . . . Ley RE (2016) Genetic determinants of the gut microbiome in UK Twins. Cell Host & Microbe 19(5):731\u2013743. https:\/\/doi.org\/10.1016\/j.chom.2016.04.017","DOI":"10.1016\/j.chom.2016.04.017"},{"key":"1798_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104621","volume":"134","author":"C Gubert","year":"2020","unstructured":"Gubert C, Kong G, Renoir T, Hannan AJ (2020) Exercise, diet and stress as modulators of gut microbiota: implications for neurodegenerative diseases. Neurobiol Dis 134:104621. https:\/\/doi.org\/10.1016\/j.nbd.2019.104621","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1798_CR36","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00125-012-2564-7","volume":"55","author":"CH Hansen","year":"2012","unstructured":"Hansen CH, Krych L, Nielsen DS, Vogensen FK, Hansen LH, S\u00f8rensen SJ, Hansen AK (2012) Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55(8):2285\u20132294. https:\/\/doi.org\/10.1007\/s00125-012-2564-7","journal-title":"Diabetologia"},{"key":"1798_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1181744","author":"L Hern\u00e1ndez-Montoliu","year":"2023","unstructured":"Hern\u00e1ndez-Montoliu L, Rodr\u00edguez-Pe\u00f1a M-M, Puig R, Astiarraga B, Guerrero-P\u00e9rez F, Virgili N, Vilarrasa N (2023) A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1181744","journal-title":"Front Endocrinol"},{"issue":"5","key":"1798_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Payami H (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"1798_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123109","author":"S Hirschberg","year":"2019","unstructured":"Hirschberg S, Gisevius B, Duscha A, Haghikia A (2019) Implications of diet and the gut microbiome in neuroinflammatory and neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20123109","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1798_CR40","first-page":"90","volume":"2","author":"M Ihlamur","year":"2024","unstructured":"Ihlamur M, Dolgun T, Tekpak S (2024) Kanser Tedavisi \u0130\u00e7in Ba\u011f\u0131rsak Mikrobiyotas\u0131n\u0131n Nanoteknoloji Mod\u00fclasyonu. [Nanotechnology Modulation of Gut Microbiota for Cancer Treatment]. K\u0131r\u015fehir Ahi Evran \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi 2(2):90\u2013104","journal-title":"K\u0131r\u015fehir Ahi Evran \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"issue":"1","key":"1798_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Weiner HL (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7(1):12015. https:\/\/doi.org\/10.1038\/ncomms12015","journal-title":"Nat Commun"},{"issue":"11","key":"1798_CR42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker M (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med 16(11):1210\u20131214. https:\/\/doi.org\/10.1038\/nm.2224","journal-title":"Nat Med"},{"issue":"12","key":"1798_CR43","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","volume":"92","author":"PC Kashyap","year":"2017","unstructured":"Kashyap PC, Chia N, Nelson H, Segal E, Elinav E (2017) Microbiome at the frontier of personalized medicine. Mayo Clin Proc 92(12):1855\u20131864. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.004","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"1798_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1139\/gen-2020-0136","volume":"64","author":"H Kaur","year":"2021","unstructured":"Kaur H, Singh Y, Singh S, Singh RB (2021) Gut microbiome-mediated epigenetic regulation of brain disorder and application of machine learning for multi-omics data analysis. Genome 64(4):355\u2013371. https:\/\/doi.org\/10.1139\/gen-2020-0136","journal-title":"Genome"},{"issue":"2","key":"1798_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, Mook-Jung I (2020) Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69(2):283\u2013294. https:\/\/doi.org\/10.1136\/gutjnl-2018-317431","journal-title":"Gut"},{"key":"1798_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.09.001","volume":"135","author":"G Kong","year":"2020","unstructured":"Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ (2020) Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 135:104268. https:\/\/doi.org\/10.1016\/j.nbd.2018.09.001","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1798_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F (2021) Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol 19(2):77\u201394. https:\/\/doi.org\/10.1038\/s41579-020-0438-4","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"1798_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.it.2017.06.003","volume":"38","author":"A Kurilshikov","year":"2017","unstructured":"Kurilshikov A, Wijmenga C, Fu J, Zhernakova A (2017) Host genetics and gut microbiome: challenges and perspectives. Trends Immunol 38(9):633\u2013647. https:\/\/doi.org\/10.1016\/j.it.2017.06.003","journal-title":"Trends Immunol"},{"issue":"7","key":"1798_CR49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.biotechadv.2016.08.003","volume":"34","author":"D Li","year":"2016","unstructured":"Li D, Wang P, Wang P, Hu X, Chen F (2016) The gut microbiota: a treasure for human health. Biotechnol Adv 34(7):1210\u20131224. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.08.003","journal-title":"Biotechnol Adv"},{"key":"1798_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1422350","author":"H Li","year":"2024","unstructured":"Li H, Cui X, Lin Y, Huang F, Tian A, Zhang R (2024) Gut microbiota changes in patients with Alzheimer\u2019s disease spectrum based on 16S rRNA sequencing: a systematic review and meta-analysis. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2024.1422350","journal-title":"Front Aging Neurosci"},{"key":"1798_CR51","doi-asserted-by":"publisher","unstructured":"Lin MY, de Zoete MR, van Putten JPM, Strijbis K (2015) Redirection of epithelial \u0131mmune responses by short-chain fatty acids through \u0131nhibition of histone deacetylases. Front Immunol 6. https:\/\/doi.org\/10.3389\/fimmu.2015.00554","DOI":"10.3389\/fimmu.2015.00554"},{"key":"1798_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.570658","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Xu F, Nie Z, Shao L (2020) Gut microbiota approach-a new strategy to treat Parkinson\u2019s disease. Front Cell Infect Microbiol 10:570658. https:\/\/doi.org\/10.3389\/fcimb.2020.570658","journal-title":"Front Cell Infect Microbiol"},{"key":"1798_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1490300","volume":"18","author":"FJ Liu","year":"2024","unstructured":"Liu FJ, Wu J, Gong LJ, Yang HS, Chen H (2024) Non-invasive vagus nerve stimulation in anti-inflammatory therapy: mechanistic insights and future perspectives. Front Neurosci 18:1490300. https:\/\/doi.org\/10.3389\/fnins.2024.1490300","journal-title":"Front Neurosci"},{"issue":"1","key":"1798_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, Khaw KY (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"issue":"44","key":"1798_CR55","doi-asserted-by":"publisher","first-page":"27516","DOI":"10.1073\/pnas.2002817117","volume":"117","author":"TL Montgomery","year":"2020","unstructured":"Montgomery TL, K\u00fcnstner A, Kennedy JJ, Fang Q, Asarian L, Culp-Hill R, Krementsov DN (2020) Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity. Proc Natl Acad Sci U S A 117(44):27516\u201327527. https:\/\/doi.org\/10.1073\/pnas.2002817117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1798_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00345","volume":"7","author":"C Mu","year":"2016","unstructured":"Mu C, Yang Y, Zhu W (2016) Gut microbiota: the brain peacekeeper. Front Microbiol 7:345. https:\/\/doi.org\/10.3389\/fmicb.2016.00345","journal-title":"Front Microbiol"},{"issue":"9","key":"1798_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13091062","volume":"13","author":"C Munteanu","year":"2024","unstructured":"Munteanu C, Galaction AI, Turnea M, Blendea CD, Rotariu M, Postaru M (2024) Redox homeostasis, gut microbiota, and epigenetics in neurodegenerative diseases: a systematic review. Antioxidants 13(9):1062","journal-title":"Antioxidants"},{"issue":"9","key":"1798_CR58","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K (2020) Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord 35(9):1626\u20131635. https:\/\/doi.org\/10.1002\/mds.28119","journal-title":"Mov Disord"},{"key":"1798_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071506","author":"S Nohesara","year":"2023","unstructured":"Nohesara S, Abdolmaleky HM, Thiagalingam S (2023) Epigenetic aberrations in major psychiatric diseases related to diet and gut microbiome alterations. Genes. https:\/\/doi.org\/10.3390\/genes14071506","journal-title":"Genes"},{"issue":"9","key":"1798_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106335","volume":"9","author":"M Nouri","year":"2014","unstructured":"Nouri M, Bredberg A, Westr\u00f6m B, Lavasani S (2014) Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS ONE 9(9):e106335. https:\/\/doi.org\/10.1371\/journal.pone.0106335","journal-title":"PLoS ONE"},{"issue":"12","key":"1798_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"Quigley EMM (2017) Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 17(12):94. https:\/\/doi.org\/10.1007\/s11910-017-0802-6","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"1798_CR62","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1055\/s-0043-119089","volume":"49","author":"N Roshanravan","year":"2017","unstructured":"Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Jafarabadi M, Alipour S, Alamdari N, Barati M, Ostadrahimi A (2017) Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Horm Metab Res 49(11):886\u2013891. https:\/\/doi.org\/10.1055\/s-0043-119089","journal-title":"Horm Metab Res"},{"issue":"7695","key":"1798_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E, Segal E (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555(7695):210\u2013215. https:\/\/doi.org\/10.1038\/nature25973","journal-title":"Nature"},{"issue":"2","key":"1798_CR64","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00415-022-11461-9","volume":"270","author":"S Ryman","year":"2023","unstructured":"Ryman S, Vakhtin AA, Richardson SP, Lin HC (2023) Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases. J Neurol 270(2):746\u2013758. https:\/\/doi.org\/10.1007\/s00415-022-11461-9","journal-title":"J Neurol"},{"key":"1798_CR65","doi-asserted-by":"publisher","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, . . . Mazmanian SK (2016) Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167(6):1469\u20131480.e1412. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","DOI":"10.1016\/j.cell.2016.11.018"},{"issue":"3","key":"1798_CR66","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Pereira PAB, Haapaniemi E, Kaakkola S, Eerola\u2010Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358. https:\/\/doi.org\/10.1002\/mds.26069","journal-title":"Mov Disord"},{"key":"1798_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, Hao Y, Gu Y, Han C (2020) New mechanism of neuroinflammation in Alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry 100:109884. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109884","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"1798_CR68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, Bae JW (2014) An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63(5):727\u2013735. https:\/\/doi.org\/10.1136\/gutjnl-2012-303839","journal-title":"Gut"},{"issue":"1","key":"1798_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02510-1","volume":"19","author":"P Sittipo","year":"2022","unstructured":"Sittipo P, Choi J, Lee S, Lee YK (2022) The function of gut microbiota in immune-related neurological disorders: a review. J Neuroinflammation 19(1):154. https:\/\/doi.org\/10.1186\/s12974-022-02510-1","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1798_CR70","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer F, B\u00e4ckhed F (2013) The gut microbiota\u2013masters of host development and physiology. Nat Rev Microbiol 11(4):227\u2013238. https:\/\/doi.org\/10.1038\/nrmicro2974","journal-title":"Nat Rev Microbiol"},{"key":"1798_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/femsml\/uqad032","author":"RA Stein","year":"2023","unstructured":"Stein RA, Riber L (2023) Epigenetic effects of short-chain fatty acids from the large intestine on host cells. Microlife. https:\/\/doi.org\/10.1093\/femsml\/uqad032","journal-title":"Microlife"},{"issue":"5","key":"1798_CR72","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","volume":"25","author":"J Suez","year":"2019","unstructured":"Suez J, Zmora N, Segal E, Elinav E (2019) The pros, cons, and many unknowns of probiotics. Nat Med 25(5):716\u2013729. https:\/\/doi.org\/10.1038\/s41591-019-0439-x","journal-title":"Nat Med"},{"key":"1798_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9112281","author":"P Sun","year":"2021","unstructured":"Sun P, Su L, Zhu H, Li X, Guo Y, Du X, Zhang L, Qin C (2021) Gut microbiota regulation and their implication in the development of neurodegenerative disease. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms9112281","journal-title":"Microorganisms"},{"key":"1798_CR74","doi-asserted-by":"publisher","unstructured":"van der Burg JM, Winqvist A, Aziz NA, Maat-Schieman ML, Roos RA, Bates GP, . . . Wierup N (2011) Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice. Neurobiol Dis 44(1):1\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2011.05.006","DOI":"10.1016\/j.nbd.2011.05.006"},{"key":"1798_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa110","author":"CI Wasser","year":"2020","unstructured":"Wasser CI, Mercieca E-C, Kong G, Hannan AJ, McKeown SJ, Glikmann-Johnston Y, Stout JC (2020a) Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaa110","journal-title":"Brain Commun"},{"issue":"2","key":"1798_CR76","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa110","volume":"2","author":"CI Wasser","year":"2020","unstructured":"Wasser CI, Mercieca EC, Kong G, Hannan AJ, McKeown SJ, Glikmann-Johnston Y, Stout JC (2020b) Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun 2(2):fcaa110. https:\/\/doi.org\/10.1093\/braincomms\/fcaa110","journal-title":"Brain Commun"},{"key":"1798_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.959856","volume":"13","author":"W Wei","year":"2022","unstructured":"Wei W, Wang S, Xu C, Zhou X, Lian X, He L, Li K (2022) Gut microbiota, pathogenic proteins and neurodegenerative diseases. Front Microbiol 13:959856. https:\/\/doi.org\/10.3389\/fmicb.2022.959856","journal-title":"Front Microbiol"},{"issue":"1","key":"1798_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2022407","volume":"14","author":"V Woo","year":"2022","unstructured":"Woo V, Alenghat T (2022) Epigenetic regulation by gut microbiota. Gut Microbes 14(1):2022407. https:\/\/doi.org\/10.1080\/19490976.2021.2022407","journal-title":"Gut Microbes"},{"key":"1798_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1583562","author":"J Xu","year":"2025","unstructured":"Xu J, Lu Y (2025) The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2025.1583562","journal-title":"Front Microbiol"},{"key":"1798_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.861035","volume":"14","author":"R Yang","year":"2022","unstructured":"Yang R, Gao G, Yang H (2022) The pathological mechanism between the intestine and brain in the early stage of Parkinson\u2019s disease. Front Aging Neurosci 14:861035. https:\/\/doi.org\/10.3389\/fnagi.2022.861035","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1798_CR81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5056\/jnm15146","volume":"22","author":"SS Yarandi","year":"2016","unstructured":"Yarandi SS, Peterson DA, Treisman GJ, Moran TH, Pasricha PJ (2016) Modulatory effects of gut microbiota on the central nervous system: how gut could play a role in neuropsychiatric health and diseases. J Neurogastroenterol Motil 22(2):201\u2013212. https:\/\/doi.org\/10.5056\/jnm15146","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"1798_CR82","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/NEN.0b013e318283114a","volume":"72","author":"ZY Zhang","year":"2013","unstructured":"Zhang ZY, Schluesener HJ (2013) Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model. J Neuropathol Exp Neurol 72(3):178\u2013185. https:\/\/doi.org\/10.1097\/NEN.0b013e318283114a","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1798_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01384-0","volume":"16","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wang W, Ye Q, Fu Y, Li X, Yang K, Gao F, Zhou A, Wei Y, Tian S, Li S, Wei F, Shi W, Li W-D (2024) Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP\/PS1 Alzheimer\u2019s disease mouse model by regulating the expression of APP secretases. Alzheimers Res Ther 16(1):15. https:\/\/doi.org\/10.1186\/s13195-024-01384-0","journal-title":"Alzheimers Res Ther"},{"key":"1798_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1576686","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, He X, Zhao Y, Zou Q, Liang Y, Zhang J, Feng B, Rong P, Wang Y (2025) Transcutaneous auricular vagus nerve stimulation regulates gut microbiota mediated peripheral inflammation and metabolic disorders to suppress depressive-like behaviors in CUMS rats. Front Microbiol 16:1576686. https:\/\/doi.org\/10.3389\/fmicb.2025.1576686","journal-title":"Front Microbiol"},{"issue":"1","key":"1798_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Chen Y, Huang W, Zhou H, Zhang W (2023) Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther 8(1):386. https:\/\/doi.org\/10.1038\/s41392-023-01619-w","journal-title":"Signal Transduct Target Ther"},{"key":"1798_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555. https:\/\/doi.org\/10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01798-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:05:40Z","timestamp":1781636740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01798-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1798"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01798-9","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"During the preparation of this work, ChatGPT tools were used to improve readability. The authors reviewed and edited the content as needed and took full responsibility for the content of the publication.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"\u00a0Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"43"}}